These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21455713)

  • 1. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.
    Pomara N; Bruno D; Nierenberg JJ; Sidtis JJ; Martiniuk FT; Mehta PD; Zetterberg H; Blennow K
    Neurochem Res; 2011 Jun; 36(6):1124-8. PubMed ID: 21455713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
    Bruno D; Pomara N; Nierenberg J; Ritchie JC; Lutz MW; Zetterberg H; Blennow K
    Exp Gerontol; 2012 May; 47(5):347-52. PubMed ID: 21983493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.
    Helisalmi S; Hall A; Meriläinen EH; Väisänen V; Koivisto AM; Herukka SK; Laitinen M; Soininen H; Hiltunen M
    Neurodegener Dis; 2014; 14(4):204-8. PubMed ID: 25500937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
    Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
    Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene.
    Hedskog L; Brohede J; Wiehager B; Pinho CM; Revathikumar P; Lilius L; Glaser E; Graff C; Karlström H; Ankarcrona M
    J Alzheimers Dis; 2012; 31(3):527-36. PubMed ID: 22596268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
    Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
    Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
    Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
    Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent associations of TOMM40 and APOE variants with body mass index.
    Kulminski AM; Loika Y; Culminskaya I; Huang J; Arbeev KG; Bagley O; Feitosa MF; Zmuda JM; Christensen K; Yashin AI;
    Aging Cell; 2019 Feb; 18(1):e12869. PubMed ID: 30462377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.
    Alexopoulos P; Guo LH; Kratzer M; Westerteicher C; Kurz A; Perneczky R
    Dement Geriatr Cogn Disord; 2011; 32(3):164-70. PubMed ID: 21997402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.
    Luo X; Qiu T; Jia Y; Huang P; Xu X; Yu X; Shen Z; Jiaerken Y; Guan X; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Oct; 11(5):1290-1301. PubMed ID: 27714554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD.
    Sabbagh MN; Pope E; Cordes L; Shi J; DeCourt B
    Expert Opin Investig Drugs; 2021 Jan; 30(1):39-44. PubMed ID: 33455481
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Chiba-Falek O; Gottschalk WK; Lutz MW
    Alzheimers Dement; 2018 May; 14(5):692-698. PubMed ID: 29524426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.